overview of haemophilus influenzae and related bacteria leonard mayer, ph. d. chief, meningitis...

16
Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Upload: rodger-smith

Post on 12-Jan-2016

215 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Overview of Haemophilus influenzae and related bacteria

Leonard Mayer, Ph. D.Chief, Meningitis Laboratory

MVPDB/DBD/CDC

1

Page 2: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

2

Haemophilus influenzae (Hi)

gram negative coccobacillus Serotypes a-f, and HiNT Meningitis, pneumonia,

sepsis, otitis media, among others

Vaccine for serotype b (Hib) Non-b Hi cases are more

visible after Hib vaccine implementation

Page 3: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Haemophilus influenzae (Hi)

Severe bacterial infection, particularly among infants Before the introduction of effective vaccines, Hi type b

(Hib) was a leading cause of bacterial meningitis in children <5 years Introduction of conjugate vaccines in 1991 in U.S. led to rapid

decline in Hi type b disease

Most disease in the United States and other developed countries is now due to non-b serotypes and nontypeable (NT) strains Now in U.S., NT currently most common; serotypes a-f less

common

3

Page 4: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Decline of Hib Meningitis Related to Vaccine Distribution

19801981

19821983

19841985

19861987

19881989

19901991

19921993

0

5

10

15

20

25

30

0

5

10

15

20

Year

Inci

den

ce (

per

100

,000

)

Do

ses

dis

trib

ute

d (

mil

lio

ns)

Polysaccharide Vaccine Conjugate Vaccine

Page 5: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

H. influenzae (Hi) Serotypes

Encapsulated Unencapsulated

Type b (Hib)

Type non - b (a, c, d, e, f)

Nontypeable (NT)

Page 6: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Encapsulated vs. Unencapsulated

• Capsule related to virulence

• NT genetically diverse

• NT viewed as colonizers

Page 7: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

H. aegypitus

• 1st described by Robert Koch while investigating cholera in Egypt in 1883

• Causes conjuntivitis (pink eye); purulent with no permanent damage

• <1986 never isolated from sterile site• Now called Haemophilus influenzae

biogroup aegyptius

Page 8: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Brasilian Purpuric Fever (BPF)

Harrison ClinMicroRev 21:594 ‘08

Page 9: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

“He got more purple . . . . I was in a room with him and the doctor asked me to leave so I wouldn’t see. And right after the doctor came out and said he had died. It was really fast. The disease didn’t even last 24 hours. It was really fast.”

Mother of a child with BPF

—What’s Killing the Children?,

NOVA documentary, WGBHTV,

Boston, MA, 18 December 1990.

Page 10: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1
Page 11: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Same unique clone by:

• Plasmid restriction profile• SDS-PAGE protein profile• rRNA “ribotyping”• MLEE• Seroagglutination• Antibiotic susceptibility testing

Page 12: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

HiNT

BPF

Page 13: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

H. haemolyticus

• “H. haemolyticus is nonpathogenic, in contrast to the pathogenic H. influenzae.” Wikipedia

• Common in carriage isolates• Biochemically similar to H. influenzae

– Require hemin (factor X) and NAD (factor V)• Lose hemolytic activity by yet un-known

mechanism

Page 14: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

Active Bacterial Core Surveillance (ABCs) Sites, 2004

OR

CA

MN

NM

CO

TN

GA

MD

NYCT

(pop. = 38.6 million)

Participating counties or states

Page 15: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1

• 2010 5 / 392• 1999+2000 4 / 234• Blood, knee fluid, peritoneal fluid……….

no CSF

Page 16: Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1